A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

about

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population Lipopeptides as the antifungal and antibacterial agents: applications in food safety and therapeutics

P2860

Q37327608-7D126D5C-C1E9-4D00-9B5C-1271A2A9E4F3 Q42180837-E148AA73-B759-4CDC-BAB9-C35F5B6E686C

P2860

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

Item

http://www.wikidata.org/entity/Q37668805

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

@en

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy.

@nl

type

Item

label

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

@en

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy.

@nl

prefLabel

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

@en

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy.

@nl

P1476

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

@en

P2093

Chih-Hsiang Leng

http://www.w3.org/2001/XMLSchema#string

Hsin-Wei Chen

http://www.w3.org/2001/XMLSchema#string

Hsueh-Hung Liu

http://www.w3.org/2001/XMLSchema#string

I-Hua Chen

http://www.w3.org/2001/XMLSchema#string

Ying-Chyi Song

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins

Dendritic cells and the control of immunity

Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling

Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice

Toll-like receptor control of the adaptive immune responses

Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties.

Dendritic cell regulation of TH1-TH2 development.

Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model.

Th cells promote CTL survival and memory via acquired pMHC-I and endogenous IL-2 and CD40L signaling and by modulating apoptosis-controlling pathways.

Recognition and signaling by toll-like receptors.

P304

349783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/349783

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Shih-Jen Liu

Pele Chong

P577

2014-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261745934

http://www.w3.org/2001/XMLSchema#string

P698

24738054

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

3967807

http://www.w3.org/2001/XMLSchema#string

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

about

P2860

P2860

A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932